4/A//SEC Filing
Gurrola Sandra M 4/A
Accession 0001140361-22-009983
CIK 0000748592other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 9:00 PM ET
Size
5.6 KB
Accession
0001140361-22-009983
Insider Transaction Report
Form 4/AAmended
Gurrola Sandra M
VP of Finance
Transactions
- Award
Stock Option (Right to buy)
2022-03-11+114,500→ 114,500 totalExercise: $1.93Exp: 2032-03-11→ Common Stock (114,500 underlying)
Footnotes (1)
- [F1]The options vest and become exercisable in 36 substantially equal monthly installments from the grant date.
Documents
Issuer
Brooklyn ImmunoTherapeutics, Inc.
CIK 0000748592
Entity typeother
Related Parties
1- filerCIK 0001618457
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 9:00 PM ET
- Size
- 5.6 KB